Direct conversion is considered a promising approach to obtain tissue-specific cells for cell therapies; however, this strategy depends on exogenous gene expression that may cause undesired adverse effects such as tumorigenesis. By optimizing the Schwann cell induction system, which was originally developed for trans-differentiation of bone marrow mesenchymal stem cells into
| INTRODUCTION
Recent efforts to direct conversion of somatic cells into other cell types have shown that tissue-specific cells such as neurons (Vierbuchen et al., 2010) , oligodendrocyte precursor cells (Najm et al., 2013; Zhu et al., 2014) , and other neural-lineage cells (Kim et al., 2014; Ring et al., 2012; Thoma et al., 2014) can be produced by gene transfer of specific transcription factors. A most recent study has even demonstrated that the combination of transcription factors required for direct conversion into any type of cells can be theoretically predicted (Rackham et al., 2016) . These induced cells are expected to be hopeful sources for cell therapies; however, most strategies for direct conversion are based on the expression of transgenes that are integrated into the genome of target cells. This genetic modification often interferes with normal gene expression and may cause adverse effects such as tumorigenesis or leukemia formation after transplantation (Hacein-Bey-Abina, Von Kalle, Schmidt, Le Deist, 2003; HaceinBey-Abina, Von Kalle, Schmidt, McCormack, 2003) . Therefore, direct conversion without gene transfer has the potential to be a safer, more feasible approach to cell therapies.
Schwann cells are glial cells that myelinate axons to allow saltatory conduction in the peripheral nervous system (PNS) (Garbay, Heape, Sargueil, & Cassagne, 2000) . They play critical roles in functional repair after PNS damage by stimulating cell proliferation, Masaaki Kitada and Toru Murakami contributed equally to this study.
producing growth factors and extracellular matrices, constructing Büngner bands that serve as scaffolds for regenerating axons to reach their target, myelinating regenerated axons, and helping synaptic connections at neuromuscular junctions (NMJs) (Allodi, Udina, & Navarro, 2012) . Furthermore, Schwann cells retain these functions after transplantation into animal models of central nervous system (CNS) injuries such as those of the optic nerve and spinal cord (Aguayo, David, & Bray, 1981; Dezawa, Kawana, & Adachi-Usami, 1997; Martin et al., 1996) and demyelinating diseases such as multiple sclerosis (BaronVan Evercooren, Avellana-Adalid, Lachapelle, & Liblau, 1997; Lavdas, Papastefanaki, Thomaidou, & Matsas, 2008; Zujovic et al., 2012) .
Thus, Schwann cells are expected to be useful in cell therapies applied to both the PNS and CNS. However, several issues have halted clinical application of Schwann cells: a healthy peripheral nerve needs to be sacrificed to harvest Schwann cells; and the technical difficulties of obtaining sufficient human Schwann cells for cell therapy through culture because of their low rate of proliferation. Therefore, a system to induce cells with functions corresponding to those of authentic Schwann cells from other, more easily accessible and highly proliferative cell types would be valuable for clinical applications.
We demonstrated for the first time that bone marrow mesenchymal stem cells (MSCs), which have the high potential to differentiate into ectodermal and endodermal cells as well as mesodermal cells (reviewed in Kitada & Dezawa, 2009; , can trans-differentiate into Schwann cells under a specific induction system (Dezawa, Takahashi, Esaki, Takano, & Sawada, 2001) . The system includes serial administration of a reducing agent, retinoic acid, and a trophic factor cocktail. Gene transfer is not needed for the induction of Schwann cells. Only 9-10 days are needed to obtain Schwann cells; therefore, the system is highly efficient, with more than 95% of MSCs trans-differentiating into cells functionally equivalent to Schwann cells (Dezawa et al., 2001) . In addition, this system was successfully applied to other mesenchymal sources, including bone marrow, adipose tissue, and umbilical cord (Kingham et al., 2007; Peng et al., 2011; Tohill, Mantovani, Wiberg, & Terenghi, 2004 ) from various animal species, including rats, rabbits, monkeys, and humans (Lu et al., 2008; Wakao et al., 2010; Wang, Luo, Li, & Hu, 2011; Xu et al., 2008) . Furthermore, transplantation of Schwann cells induced from macaque monkey bone marrow MSCs showed the long-term safety of this induction system and suggested the feasibility of its use . Therefore, clinical application of this Schwann cell induction system is expected to be valuable for the treatment of PNS and CNS injury and demyelinating diseases.
In this study, we asked the possibility to apply adult human skin fibroblasts, whose origin is the same as that of MSCs but that are considered highly differentiated cells, to this induction system for direct conversion into functional Schwann cells. Because fibroblasts are easily accessible and can be expanded to clinical scale with reasonable time and cost, successful conversion of fibroblasts into functional Schwann cells would be of great interest. We examined the properties of adult human skin fibroblasts treated with the Schwann cell induction system in vitro and validated their neuro-regenerative functions in vivo by grafting these cells into a rat PNS injury model.
| MATERIALS AND METHODS

| Cultures
Adult human skin fibroblasts were purchased from Lonza (normal human dermal fibroblasts-adult, Basel, Switzerland). They were maintained in α-modification Eagle's minimal essential medium (α-MEM; M4526, Sigma-Aldrich, St. Louis, MO, USA) with 10% fetal bovine serum (FBS; Hyclone, GE Healthcare Life Sciences, South Logan, UT, USA) and 0.1 mg/mL kanamycin (Gibco, Thermo Fisher Scientific, Waltham, MA, USA). Human Schwann cells (described hereafter as "primary human Schwann cells" [ScienCell, Carlsbad, CA, USA]), were maintained in Schwann cell medium (ScienCell).
| Direct conversion of fibroblasts into Schwann cells
Fibroblasts were treated with the Schwann cell induction system, which was originally developed by Dezawa et al. for the transdifferentiation of bone marrow MSCs into Schwann cells (Dezawa et al., 2001) . We optimized this system to directly convert adult human skin fibroblasts into Schwann cells (hereafter described as "induced Schwann cells"). A schematic illustration of this induction system with optimization is shown in Figure 1 . Adult human skin fibroblasts from passage 5 to 9 were plated at a density of 790 cells/cm 2 with 10% FBS in α-MEM. On the next day, the medium was changed to α-MEM containing 1 mM β-mercaptoethanol (BME) without serum, and the cells were incubated for another 24 hr. The medium was then replaced with α-MEM containing 10% FBS and 35 ng/mL all-trans retinoic acid (RA; Sigma-Aldrich). Three days later, the cells were washed with phosphate-buffered saline (PBS) and cultured in a medium comprising α-MEM, 10 ng/mL recombinant human basic fibroblast growth factor (bFGF; Wako, Osaka, Japan), 5 μM forskolin (Millipore, Darmstadt, Germany), 10 ng/mL platelet-derived growth factor-AA (PDGF-AA; Peprotech, Rocky Hill, CT, USA), and 200 ng/ mL heregulin-β1-EGF domain (HRG; R&D Systems, Minneapolis, MN, USA) for 4 days. To optimize this induction system, medium with 10, 5, or 1% FBS was used during the treatment with the cocktail of trophic factors, and the effects of the different FBS concentrations were compared (Figure 1 ).
| Flow cytometry and fluorescence-activated cells sorting (FACS)
For analyzing the cell surface antigen expression, cultured cells were 
| Immunocytochemistry
Cultured cells were fixed with 4% paraformaldehyde (PFA) in 0.1 M phosphate buffer (PB) and subjected to immunocytochemistry as described previously (Kuroda et al., 2013) . After blocking, cells were incubated with one of the following primary antibodies: anti-p75 nerve growth factor (NGF) receptor (p75) mouse IgG (1:500; Abcam, Cambridge, England), anti-protein zero (P0) mouse IgG (1:100; kindly provided by Dr. J. J. Archelos, Karl-Franzens Universitat, Graz, Austria), anti-GFAP rabbit IgG (1:300; DAKO, Glostrup, Denmark), anti-S100 rabbit IgG (1:800; DAKO), anti-O4 mouse IgM (1:50; Millipore), anti-Sox10 rabbit IgG (1:500; Abcam), anti-POU3F1 mouse IgG (1:300; Santa Cruz, Dallas, TX, USA), and anti-Krox20 mouse IgG (1:100; OriGene, Rockville, MD, USA). The secondary antibodies used for immunocytochemistry were labeled with Alexa Fluor 488 or 568:
anti-mouse Ig donkey IgG and anti-rabbit Ig donkey IgG (1:500; Thermo Fisher Scientific, Carlsbad, CA, USA). Nuclei were counterstained with 4 0 ,6-diamidino-2-phenylindole (DAPI, Sigma-Aldrich).
| Reverse-transcription polymerase chain reaction (RT-PCR)
mRNAs were purified using an RNeasy Mini Kit (Qiagen, Venlo, Netherlands), and then complementary DNA (cDNA) was reversetranscribed with SuperScript III Reverse Transcriptase (Thermo Fisher Scientific) following the manufacturer's protocol.
The following primers were used for the amplification of specific tubes (Millipore) to prepare artificial grafts as previously described (Matsuse et al., 2010; Shimizu et al., 2007) . In total, 1.0 × 10 5 cells were added to each graft, except for the Matrigel-only group.
| Transplantation to the severed peripheral nerve in rats
Complete transection of the peripheral nerve in rats and transplantation of the artificial graft containing the cultured cells were performed as previously described (Matsuse et al., 2010; Shimizu et al., 2007) .
Briefly, a segment of the sciatic nerve in each animal was removed from the middle of the left thighbone under general anesthesia with isoflurane to create a 5-mm gap. Transplantation was performed by connecting the gap with the artificial graft containing the cells using 10-0 nylon sutures. For the negative control, animals were transplanted with tubes containing only Matrigel. Six animals were used per group for the fibroblast and induced Schwann cell groups, seven animals were used for the primary human Schwann cell group, and five animals were used for the Matrigel-only group. After transplantation of the artificial grafts, 0.5 mg/kg FK506 (Astellas Pharma, Inc., Tokyo, Japan) was administrated subcutaneously each day for immunosuppression. We made an autograft model as another control: a complete transection of the sciatic nerve to make a 6-mm gap as described above, and tied the removed segment to the sciatic nerve again by suturing. Four animals were used for the autograft group.
| Immunohistochemistry
Six weeks after transplantation, transcardial perfusion with periodatelysine-paraformaldehyde fixatives was performed under an overdose of anesthesia, and the sciatic nerve, including the artificial graft and the flexor digitorum brevis muscle, was dissected from the affected side of the rat. The tissues were fixed using the same fixatives at 4 C overnight. These fixatives were successively displaced by 15, 20, and 25% sucrose in 0.02 M PBS. The tissues were embedded in OCT compound, frozen on dry ice, and sliced into 10-μm sections.
After blocking, the tissues were incubated with one of the follow- To assess the number of axons in each portion of the graft, transverse sections from three animals in each transplanted group were made. The sections were cut at 2-, 4-, and 6-mm from the proximal end of the graft. After immunostaining for neurofilament and MBP in the transverse sections at the 6-mm position from the proximal end of the graft, the numbers of axons and myelinated axons observed was counted using Image J (National Institutes of Health, Bethesda, MD, USA). In the transverse section of the graft, we determined "the outer area" of the graft as the area near by the wall of the graft tube, whose distance from the tube was up to 300 μm. Also, "the inner area" in the transverse section of the graft was determined as the circular area containing the center of the graft, whose diameter was up to 300 μm.
To estimate the reformation of NMJs, sections parallel to the flexor digitorum brevis muscle were cut and subjected to double staining for synaptophysin and with FITC-labeled α-bungarotoxin (1:100; Thermo Fisher Scientific). NMJs in each section were manually counted in six sections per animal from at least three animals. The number of NMJs in the uninjured animals was also evaluated.
| Conventional electron microscopy
Six weeks after transplantation, animals of the fibroblast group was transcardial perfused with 2.5% glutaraldehyde and 2.0% paraformaldehyde in 0.1 M phosphate buffer (PB) under an overdose of anesthesia, and the sciatic nerve including the artificial graft was dissected from the affected side of the rat. The tissues were further fixed using the same fixatives at 4 C overnight, washed in 0.1 M PB, and post-fixed with 1.0% osmium tetroxide in 0.1 M PB. The samples were dehydrated with the sequential concentration of ethanol and propylene oxide, substituted to epoxy resin, cut into ultrathin section, and observed under electron microscope (JEM-1011, JEOL, Akishima, Tokyo, Japan).
| Immunoelectron microscopy
Immunoelectron microscopy was performed as previously described (Kitada, Chakrabortty, Matsumoto, Taketomi, & Ide, 2001) . Briefly, the rats were deeply anesthetized by inhalation of isoflurane and perfused through the heart with 4% PFA/0.1 M PB 6 weeks after transplantation of the artificial nerve graft containing induced Schwann cells. The sciatic nerve was excised, post-fixed with the same fixatives, and treated with the same procedure described in the "Immunocytochemistry" section. Sections were incubated with 20% Block Ace (DS Pharma Biomedical, Osaka, Japan), 5% bovine serum albumin (BSA, Nacalai Tesque), 0.01% saponin, and 0.02 M PBS for 1 hr, followed by incubation with anti-GFP rabbit IgG (Abcam) in 5% Block Ace, 1% BSA, 0.01% saponin, and 0.02 M PBS two overnights at 4 C. Sections were then incubated with antirabbit IgG goat IgG conjugated to 1.4 nm Nanogold (Nanoprobes Inc., Stony Brook, NY) two overnights at 4 C. The signal of Nanogold was enhanced using HQ Silver (Nanoprobes) for visualization by electron microscopy.
| Behavioral analysis
A walking track analysis was performed every week for 6 weeks after transplantation as previously described (Bain, Mackinnon, & Hunter, 1989; Matsuse et al., 2010; Shimizu et al., 2007; Varejao, Meek, Ferreira, Patricio, & Cabrita, 2001 ). The hind feet of the rats were painted uniformly with black finger paint. The animal was allowed to walk on the paper in a tunnel, leaving its footprints. We measured the distance between (1) heel and toe (PL), (2) the first and fifth toe (TS), and (3) the second and fourth toe, and then calculated the sciatic function index (SFI) according to the following formula (e = experimental side, n = normal side):
2.14 | Statistical analysis The SFI scores were 6, 7, 6, 3, and 3 for the induced Schwann cell, primary human Schwann cell, fibroblast, Matrigel-only, and autograft groups, respectively.
3 | RESULTS
| Optimization of the induction system for direct conversion of human fibroblasts into Schwann cells
In previous reports of Schwann cell induction from bone marrow and umbilical cord MSCs, 10% FBS was used for culture (Dezawa et al., 2001; Matsuse et al., 2010; Shimizu et al., 2007) . However, adult human skin fibroblasts proliferate faster than MSCs when they are cultured in 10% FBS, and they become over-confluent in the early phase of the final induction step. Hence, they fail to convert into Schwann cells. Therefore, we tested three FBS concentrations, 10, 5, and 1%, in the final induction step to compare induction efficiency.
Naïve fibroblasts have large, flattened cytoplasm. Following sequential treatments with BME, RA, and trophic factors, some of fibroblasts gradually changed their morphology to a small, spindle-shaped, which was similar to that of authentic primary human Schwann cells ( Figure 2a ). We then measured the percent of cells that were positive for p75, a marker for neural crest cells, Schwann cell precursors, and mature Schwann cells (Jessen & Mirsky, 2005) . The percentages of p75-positive cells in 10, 5, and 1% FBS were 48.8 ± 1.4%, 74.6 ± 0.6%, and 50.8 ± 4.7%, respectively, indicating that the highest proportion was found in 5% FBS (Figure 2b ). In addition, Schwann cell marker S100B (Jessen et al., 1994) was only detected by RT-PCR in 5% FBS (Figure 2c ). Based on these results, we eventually selected 5% FBS as the best serum concentration during the final step of the induction of Schwann cells from adult human skin fibroblasts.
| Assessment of fibroblast-derived Schwann cells
The expression of authentic Schwann cell markers in induced Schwann cells was analyzed. Immunocytochemistry was performed with antibodies against p75, P0 (a marker for Schwann cell precursors and immature and mature Schwann cells [Lee et al., 1997] ), GFAP (a marker for immature and nonmyelinating Schwann cells [Jessen, Morgan, Stewart, & Mirsky, 1990; Mirsky et al., 2008] ), S100, and O4
(a marker for immature and mature Schwann cells [Dong et al., 1999] ).
Although none of these markers were detected in naïve fibroblasts, the percentage of induced Schwann cells that were positive for P0, GFAP, S100, and O4 were 22.8 ± 5.8%, 51.9 ± 3.1%, 56.4 ± 8.0%, and 16.9 ± 1.2%, respectively. The percentage of fibroblasts that were p75 positive was 74.6 ± 0.6%, as shown above. Authentic primary human Schwann cells were also positive for p75, P0, GFAP, S100, and O4, with percentages of cells that were positive of 60.2 ± 1.5%, 36.7 ± 4.7%, 41.1 ± 2.3%, 59.3 ± 7.3%, and 32.4 ± 4.4%, respectively (Figure 3a ). The expression of other Schwann cell markers such as Sox10, POU3F1, and Krox20 in induced Schwann cells was also confirmed (Supporting Information Figure S1 ), and double immunostaining for p75/S100, p75/GFAP, and Sox10/POU3F1 demonstrated that the same cells jointly expressed these Schwann cell markers (Supporting Information Figure S2 ).
We (Finzsch et al., 2010; Schreiner et al., 2007; Stolt & Wegner, 2016; Wegner, 2000; Weider & Wegner, 2017; Woodhoo & Sommer, 2008) , and KROX20 (a transcription factor expressed from was significantly higher than that in the fibroblast group (40.4 ± 2.72 axons/1000 μm 2 ), whereas there was no statistical difference between the induced Schwann cell and primary human Schwann cell (532.0 ± 45.6 axons/1000 μm 2 ) groups (Supporting Information Figure S4 ). These findings suggest that transplantation of induced Schwann cells promote axonal regeneration to an extent that is comparable to that of primary human Schwann cells.
| The myelination ability of induced Schwann cells after transplantation
Myelination of regenerated axons is the other important function of
Schwann cells in nerve regeneration. To examine the myelination ability of induced Schwann cells after transplantation, we performed Figure S5 ). These findings demonstrate that induced Schwann cells have the ability to myelinate regenerated axons after transplantation and suggest that the extent of the myelination ability is almost compatible to that of primary human Schwann cells. 
| Functional repair of the sciatic nerve after transplantation of induced Schwann cells
To evaluate the degree of functional recovery after transplantation of induced Schwann cells, we measured the SFI score every week for 6 weeks after transplantation (Figure 7 ). An SFI score of zero indicates normal function of the sciatic nerve, while a score of −100 means total dysfunction of the nerve (Bain et al., 1989; Varejao et al., 2001 ).
An increase of the SFI score in the induced Schwann cell group was observed beginning at 2 weeks after transplantation, and the score gradually increased over the observation period. While the SFI score of the fibroblast group was almost the same as that of the Matrigelonly group at all time points, the score for the induced Schwann cell group was significantly higher than that in the Matrigel-only group at time points from 2 to 6 weeks after transplantation. Notably, no significant differences were observed between the scores of the induced Schwann cell and human Schwann cell groups over the observation period. The autograft group exhibited greater scores than any other groups, but there were no statistical differences compared with those observed in the induced Schwann cell group at any time points. These data demonstrate that induced Schwann cells can promote functional recovery of the severed peripheral nerve after transplantation and suggest that the degree of recovery is comparable to that from primary human Schwann cells.
| Re-formation of NMJs on the flexor digitorum brevis muscle
An improvement in SFI scores indicates that regenerated axons have reached flexor and extensor muscles on the affected side of the foot and re-formed NMJs to achieve well-coordinated movement of these muscles. We estimated re-formation of NMJs in the flexor digitorum brevis muscle, which is one of the important flexor muscles in the foot innervated with the sciatic nerve, and whose NMJs can be easily observed and evaluated after injury (Csillik, Nemcsok, Chase, Csillik, & Knyihar-Csillik, 1999) . While the post-synaptic side of NMJs can be detected by α-bungarotoxin, which binds to the nicotinic acetylcholine receptor (AchR), the spread localization or even ectopic expression of AchR were reported after denervation caused by complete transection of the sciatic nerve (Csillik et al., 1999) . groups, we observed the fine structure of the graft of the fibroblast group (Supporting Information Figure S6 ). We found small vessels, in which an endothelial cell intimately contacted to a Schwann cell through the basement membrane in the outer area of the graft at the 6-mm position (Supporting Information Figure S6A ), suggesting the migration of Schwann cells on the newly formed vessels, which enhanced axonal regeneration (Cattin et al., 2015) . In the outer area, there were many myelinated axons and mature Schwann cells tightly packed within the cellular processes of fibroblasts, indicating the mature re-constructed nerve tissue (data not shown). However, we also found the loose area lacking vessels, where there were many unmyelinated axons in addition to myelinated axons both wrapped by Schwann cells in the inner area of the graft at the 6-mm position (Supporting Information Figure S6B ), suggesting immature re-constructing nerve tissue. In such loose area, extracellular matrices were obviously observed. These findings imply that host Schwann cells of the proximal end of the host nerve initially migrate into the graft, tracing on the surface of newly formed vessels to facilitate and support axonal regeneration in the outer area of the graft, enabling the relatively fast re-construction of nerve tissue, whereas such vessel-assisted Schwann cell migration mechanism does not impact on axonal regeneration in the inner area of the graft and axons relatively slowly regenerate, being guided by Schwann cells driven by extracellular matrices and trophic factors derived from Matrigel.
| The character of adult human skin fibroblasts
To characterize the adult human skin fibroblasts used in this study, we analyzed the cell surface antigen expression by flow cytometry (Supporting Information Figure S7 ). Most of them expressed CD44, CD73, and CD90, whereas they did not express CD34 and CD45 on their cellular surface, showing the mesenchymal character of this cell population and no contamination of blood cells. Since these cell
Recovery of sciatic nerve function in the induced Schwann cell group. Walking track analysis based on the sciatic function index (SFI) score evaluated up to 6 weeks after transplantation. SFI scores from 2 to 6 weeks were significantly improved in the induced Schwann cell (induced Schwann) and primary human Schwann cell (primary Schwann) groups compared with the fibroblast (fibroblast) and Matrigel-only groups. There were no significant differences in scores between the induced Schwann cell and primary human Schwann cell groups over the observation period. Also, the fibroblast group showed no significant differences from the Matrigel-only group. The autograft group showed better scores than any other groups, but no statistical differences were detected in the SFI scores between the autograft and induced Schwann cell groups at any time points [Color figure can be viewed at wileyonlinelibrary.com] surface expression pattern of adult fibroblasts has been also reported in many previous studies (Blasi et al., 2011; Itoh et al., 2013) , our method for Schwann cell induction from human adult skin fibroblasts is considered applied to other regular human fibroblasts.
There is a concern that adult human skin fibroblasts used in this study contain a very low percentage of stem/progenitor cell populations, which can produce Schwann cells under the differentiation mechanism but not through direct reprogramming. To assess this possibility, we evaluated the contamination of such cell populations by flow cytometry (Figure 9 ). There are small populations, which expressed CD271 (a cell surface marker of neural crest-derived stem cells) (Nagoshi et al., 2008) , CD117 (melanoblasts) (Nishimura et al., 2002) , or Stage-specific embryonic antigen-3 (SSEA-3) (multilineagedifferentiating stress enduring cells) (Kuroda et al., 2010; ( Figure 9a Schwann cell group and that functional recovery was significantly more efficient in these groups than in the fibroblast group. We also Xenopus and rats, where transforming growth factor beta-1 (TGF-ß1) plays a pivotal role (Feng & Ko, 2008a , 2008b . The signal of TGF-ß1 secreted by Schwann cells is mediated by its receptor, TGF receptor type II, which localizes to the axonal membrane of spinal neurons (Jiang, McLennan, Koishi, & Hendry, 2000) . With the TGF-ß1 signaling, neurons synthesize and secrete agrin, a heparan sulfate proteoglycan that is indispensable for synaptogenesis (Gautam et al., 1996) , and stimulate the aggregation of AchR in the post-synaptic membrane to promote synaptogenesis (Reist, Werle, & McMahan, 1992) . This TGF-ß1-mediated agrin secretion mechanism might account for the enhancement of NMJ re-formation observed in the present study.
A variety of neural diseases, both in and CNS including traumatic neural injuries, including peripheral nerve injury, optic nerve injury, and spinal cord injury, as well as demyelinating diseases such as multiple sclerosis, could be targets of Schwann cell-based therapies (Aguayo et al., 1981; Baron-Van Evercooren et al., 1997; Dezawa et al., 1997; Lavdas et al., 2008; Martin et al., 1996; Zujovic et al., 2012) . Using a simple method and in a relatively short period of time, our system enabled obtaining a large number of functional Schwann cells applicable to the treatment of various neural injuries and diseases mentioned above from easily accessible adult human skin fibroblasts.
| The function of induced Schwann cells as regenerative cells in the peripheral nerve injury
In the peripheral nerve after injury, myelin-forming mature Schwann 4.3 | Merits of the Schwann cell induction system used in this study
As we originally developed this induction system for transdifferentiation of bone marrow MSCs into Schwann cells, many studies, including ours and those of other research groups, have demonstrated that this system is valid for the trans-differentiation of MSCs from many kinds of tissues, including bone marrow, adipose tissue, and umbilical cord (Kingham et al., 2007; Peng et al., 2011; Tohill et al., 2004 ) from various animal species such as rats, rabbits, monkeys, and humans (Lu et al., 2008; Wakao et al., 2010; Wang et al., 2011; Xu et al., 2008) into Schwann cells. This induction system is highly efficient, with more than 95% of MSCs trans-differentiating into Schwann cells that can support axonal regeneration and myelinate regenerated axons to achieve functional recovery in the PNS and CNS after transplantation (Dezawa et al., 2001; Kamada et al., 2005) .
In addition, the safety of this induction system has already been demonstrated by a one-year observational study, which confirmed the lack of toxicity and tumorigenesis. Safety was evaluated by monitoring the general condition, cell proliferation, and positron emission tomography with fludeoxyglucose of a primate model of PNS injury after autologous transplantation of the Schwann cells .
In addition, many modifications of this induction system have been reported. In the present study, we evaluated this induction system for direct conversion of adult human skin fibroblasts into Schwann cells and demonstrated the successful induction of functional Schwann cells, which facilitated functional recovery of the severed PNS nerve after transplantation, by supporting axonal regeneration, myelination of regenerated axons, and re-formation of NMJs at a level comparable to those seen with primary human Schwann cells.
Thus, the merits of this Schwann cell induction system mentioned above are expected to be also applicable to adult human fibroblasts, and this induction system may serve as a practical tool for direct conversion of fibroblasts into Schwann cells for clinical use.
| The character of induced Schwann cells
In this study, we performed genome-wide gene expression profiling by RNA-seq (Figure 4 and Supporting Information Figure S3 ). The heatmap and clustering analysis showed that induced Schwann cells exhibited some aspects of the characteristics of mesenchymal cells, however, gene set enrichment analysis demonstrated the downregulation of the development and function of mesenchymal cells. On the other hand, up-regulation of the cell signaling-associated gene sets for Wnt, bFGF, BMP, and TGF-beta were confirmed. The cell signaling of Wnt, bFGF, and BMP are known to induce the neural crestlineage cells (Villanueva et al., 2002) , and TGF-beta signaling is reported to induce cell proliferation and block myelin gene expression in Schwann cells and their precursors (Jacob et al., 2008; Stewart et al., 1995) . In addition, the expression profile of the cell cycleassociated gene set implies the proliferation potential of induced Schwann cells might be lower than fibroblasts but higher than primary human Schwann cells (Supporting Information Figure S3C ). Wellknown, the proliferation potential of primary human Schwann cells is much lower than that of fibroblasts, so that cytosine arabinoside is typically used for the elimination of contaminating fibroblasts in primary human Schwann cell culture (Brockes, Fields, & Raff, 1979) . As are some studies that have shown the multi-potentiality of fibroblasts (Dastagir et al., 2014; Sudo et al., 2007) , these cells are generally considered to be differentiated, so that, unlike MSCs, their differentiation potential is not considered sufficient for clinical application (Brohem et al., 2013) . In contrast, fibroblasts can be harvested from the skin much more easily than MSCs, and, similar to MSCs, they can be collected from the patient without ethical concerns. In addition, they are one of the most widely distributed, commercially available human cell lines, and they can be readily expanded for clinical and industrial use.
If it is possible to obtain the needed cells by direct conversion from fibroblasts without gene transfer, they will be considered one of the most promising cell sources for clinical application. In this study, we demonstrated direct reprogramming of fibroblasts into functional Schwann cells without gene transfer. Recent studies have shown that a certain type of tissue cell, namely neurons, can be induced with direct conversion methods using only a cocktail of small molecules (Hu et al., 2015; Li et al., 2015) , further suggesting the possibility that the cells on demand are obtainable by direct conversion without gene transfer. Thus, fibroblasts will be broadly utilized as a realistic cell source for clinical applications. 
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